Question 1

What are the most cited papers from VaxTrials (Panama)?

Accepted Answer

The most cited paper from VaxTrials (Panama) is "Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial" (Edwin Jose Asturias, Ananda Sankar Bandyopadhyay, Steve G Self et al., 2016), with 83 citations. Next come "Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials" (81) and "Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study" (77).

Question 2

Which research topics does VaxTrials (Panama) publish most on?

Accepted Answer

By volume in 2022-now: Viral gastroenteritis research and epidemiology, Respiratory viral infections research, Viral Infections and Immunology Research and Pneumonia and Respiratory Infections.

Question 3

Which fields of science does VaxTrials (Panama) work in?

Accepted Answer

In all years, 88% of research at VaxTrials (Panama) is in Health Sciences, 8% in Social Sciences. Its largest fields are Medicine (83%), Mathematics (4%), Health Professions (4%). It does 1.4× the world's share of Health Sciences.

Question 4

Is VaxTrials (Panama)'s research output growing?

Accepted Answer

Output in 2022-2025 was 183% higher than in 2018-2021.